A detailed history of Susquehanna International Group, LLP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 11,452 shares of TMDX stock, worth $921,656. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,452
Previous 49,600 76.91%
Holding current value
$921,656
Previous $7.47 Million 75.94%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$135.68 - $176.11 $1.55 Million - $2.02 Million
11,452 New
11,452 $1.8 Million
Q1 2024

May 07, 2024

BUY
$70.86 - $89.93 $6.43 Million - $8.16 Million
90,706 Added 455.08%
110,638 $8.18 Million
Q4 2023

Feb 14, 2024

SELL
$36.74 - $81.08 $1.19 Million - $2.63 Million
-32,381 Reduced 61.9%
19,932 $1.57 Million
Q3 2023

Nov 14, 2023

BUY
$53.47 - $96.07 $661,798 - $1.19 Million
12,377 Added 30.99%
52,313 $2.86 Million
Q2 2023

Aug 11, 2023

BUY
$66.23 - $88.73 $1.81 Million - $2.42 Million
27,279 Added 215.53%
39,936 $3.35 Million
Q1 2023

May 16, 2023

BUY
$53.63 - $82.33 $678,794 - $1.04 Million
12,657 New
12,657 $958,000
Q3 2022

Nov 14, 2022

SELL
$31.56 - $55.75 $205,960 - $363,824
-6,526 Reduced 40.27%
9,678 $404,000
Q2 2022

Aug 15, 2022

BUY
$20.56 - $32.15 $101,977 - $159,464
4,960 Added 44.11%
16,204 $510,000
Q1 2022

May 16, 2022

SELL
$12.58 - $26.94 $376,292 - $805,829
-29,912 Reduced 72.68%
11,244 $303,000
Q2 2021

Aug 11, 2021

SELL
$21.63 - $40.07 $1.04 Million - $1.93 Million
-48,220 Reduced 53.95%
41,156 $1.37 Million
Q1 2021

May 17, 2021

BUY
$17.75 - $47.82 $1.01 Million - $2.72 Million
56,807 Added 174.42%
89,376 $3.71 Million
Q4 2020

Feb 16, 2021

BUY
$11.91 - $19.9 $185,462 - $309,882
15,572 Added 91.62%
32,569 $648,000
Q3 2020

Nov 16, 2020

BUY
$13.78 - $18.84 $234,218 - $320,223
16,997 New
16,997 $234,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.56B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.